Vaxxinity

📍 Cape Canaveral, United States👥 77 employees💰 Last funded Aug 2020
Biotechnology Research🌐 vaxxinity.com
Website LinkedIn
Vaxxinity is a U.S.-based global biotechnology company pioneering a new class of medicines to democratize health. Headquartered in Dallas, TX, with operations in the United States, Latin America, Europe and Asia, the company’s proprietary technology platform has enabled the innovation of synthetic peptide vaccines designed to prevent or treat infectious diseases, including COVID-19, and chronic diseases, including Alzheimer's, Parkinson’s, migraine, and hypercholesterolemia.. Vaxxinity has optimized its pipeline to achieve a potentially historic, global impact on human health. The key to the platform is the proprietary library of UBITh peptides, which are immunosilent, avoiding inflammation, and when linked to custom-designed target antigens, can elicit highly specific antibodies.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Vaxxinity?
Vaxxinity has 2 investors on record on gritt.io.
When did Vaxxinity last raise funding?
The most recent investment in Vaxxinity recorded on gritt.io was in August 2020.
What industry is Vaxxinity in?
Vaxxinity operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Vaxxinity based?
Vaxxinity is headquartered in Cape Canaveral, United States.